These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38026970)

  • 1. Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study.
    Hakamifard A; Radmehr R; Sokhanvari F; Sherkat F; Hariri A; Varshosaz J; Shahmoradi Z; Feizi A; Abtahi-Naeini B; Pourmahdi-Boroujeni M
    Front Pharmacol; 2023; 14():1280240. PubMed ID: 38026970
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime.
    Zabolinejad N; Layegh P; Abbasi Shaye Z; Salehi M; Ghanizadeh S
    J Dermatolog Treat; 2022 May; 33(3):1418-1423. PubMed ID: 32972289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by
    Eskandari SE; Khamesipour A; Jaafari MR; Javadi A; Mohammadi AM; Valian HK; Nassiri-Kashani M; Goyonlo VM; Firooz A
    Iran J Microbiol; 2021 Oct; 13(5):718-723. PubMed ID: 34900170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.
    Layegh P; Rajabi O; Jafari MR; Emamgholi Tabar Malekshah P; Moghiman T; Ashraf H; Salari R
    J Parasitol Res; 2011; 2011():656523. PubMed ID: 22174993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    Sadeghian G; Nilforoushzadeh MA
    Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study.
    Abtahi-Naeini B; Hadian S; Sokhanvari F; Hariri A; Varshosaz J; Shahmoradi Z; Feizi A; Khorvash F; Hakamifard A
    Iran J Pharm Res; 2021; 20(2):383-389. PubMed ID: 34567168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
    Rajabi O; Layegh P; Hashemzadeh S; Khoddami M
    Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.
    López-Jaramillo P; Rincón MY; García RG; Silva SY; Smith E; Kampeerapappun P; García C; Smith DJ; López M; Vélez ID
    Am J Trop Med Hyg; 2010 Jul; 83(1):97-101. PubMed ID: 20595484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
    Khamesipour A; Mohammadi A; Jaafari M; Eskandari S; Tasbihi M; Javadi A; Afshari F; Mortazavi H; Firooz A
    East Mediterr Health J; 2022 Sep; 28(9):658-663. PubMed ID: 36205204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial.
    Farajzadeh S; Heshmatkhah A; Vares B; Mohebbi E; Mohebbi A; Aflatoonian M; Eybpoosh S; Sharifi I; Aflatoonian MR; Shamsi Meymandi S; Fekri AR; Mostafavi M
    J Parasit Dis; 2016 Dec; 40(4):1159-1164. PubMed ID: 27876906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial.
    Farajzadeh S; Esfandiarpour I; Haghdoost AA; Mohammadi S; Mohebbi A; Mohebbi E; Mostafavi M
    Iran J Parasitol; 2015; 10(1):1-8. PubMed ID: 25904940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis.
    Alizadeh Z; Shirzadi MR; Hassanpour GR; Keshavarz H; Mohebali F; Eskandari SE; Zeinali M; Shirmohammad S; Mohebali M
    Iran J Parasitol; 2023; 18(4):419-426. PubMed ID: 38169758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio-Ben) along with cryotherapy: a single-blind randomized clinical trial.
    Daie Parizi MH; Karvar M; Sharifi I; Bahrampour A; Heshmat Khah A; Rahnama Z; Baziar Z; Amiri R
    Dermatol Ther; 2015; 28(3):140-6. PubMed ID: 25847678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
    BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran.
    Abdellahi L; Hejazi SH; Amirmozafari N; Sotoodehnejadnematalahi F
    Arch Iran Med; 2020 Nov; 23(11):740-748. PubMed ID: 33220690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.
    Farajzadeh S; Ahmadi R; Mohammadi S; Pardakhty A; Khalili M; Aflatoonian M
    J Parasit Dis; 2018 Dec; 42(4):616-620. PubMed ID: 30538362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R; Handjani F; Nouhpisheh MK
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.